Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bhagyashri Navalkele

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The American Journal of the Medical Sciences|October 23, 2025
Strategies for the prevention and control of Mpox: A review articleBhagyashri Navalkele, Heather Carlson, Rita Wilson Dib
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2017
Reply to ManianJason M Pogue, Bhagyashri Navalkele, Keith S Kaye
Archives of Pathology & Laboratory Medicine|September 27, 2019
How the Pathologist Can Help the Surgeon Collect Better Specimens for Microbiology CultureLisa M Stempak, Charles E Middleton Iv, Bhagyashri Navalkele, et al.
American Journal of Infection Control|June 8, 2020
Health care personnel exposure to a patient with asymptomatic SARS-CoV2 infection during a prolonged surgical interventionJose Lucar, Bhagyashri Navalkele, Blake P Becker, et al.
Open Forum Infectious Diseases|August 10, 2018
Impact of a Multidisciplinary Infection Prevention Initiative on Central Line and Urinary Catheter Utilization in a Long-term Acute Care HospitalSuganya Chandramohan, Bhagyashri Navalkele, Ammara Mushtaq, et al.
Antimicrobial Agents and Chemotherapy|September 2, 2015
Clinical and economic benefits of fidaxomicin compared to vancomycin for Clostridium difficile infectionJason C Gallagher, Joseph P Reilly, Bhagyashri Navalkele, et al.
Open Forum Infectious Diseases|May 29, 2020
Seizures in an Immunocompetent Adult From Treatment of Latent Tuberculosis Infection: Is Isoniazid to Blame?Bhagyashri Navalkele, Maria X Bueno Rios, John D Wofford, et al.
American Journal of Infection Control|March 12, 2018
Comparison of complications in midlines versus central venous catheters: Are midlines safer than central venous lines?Ammara Mushtaq, Bhagyashri Navalkele, Maninder Kaur, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2016
Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial StewardshipShigehiko Karino, Keith S Kaye, Bhagyashri Navalkele, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2016
Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin-Tazobactam Compared to Those on Vancomycin and CefepimeBhagyashri Navalkele, Jason M Pogue, Shigehiko Karino, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The American Journal of the Medical Sciences|October 23, 2025
Strategies for the prevention and control of Mpox: A review articleBhagyashri Navalkele, Heather Carlson, Rita Wilson Dib
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2017
Reply to ManianJason M Pogue, Bhagyashri Navalkele, Keith S Kaye
Archives of Pathology & Laboratory Medicine|September 27, 2019
How the Pathologist Can Help the Surgeon Collect Better Specimens for Microbiology CultureLisa M Stempak, Charles E Middleton Iv, Bhagyashri Navalkele, et al.
American Journal of Infection Control|June 8, 2020
Health care personnel exposure to a patient with asymptomatic SARS-CoV2 infection during a prolonged surgical interventionJose Lucar, Bhagyashri Navalkele, Blake P Becker, et al.
Open Forum Infectious Diseases|August 10, 2018
Impact of a Multidisciplinary Infection Prevention Initiative on Central Line and Urinary Catheter Utilization in a Long-term Acute Care HospitalSuganya Chandramohan, Bhagyashri Navalkele, Ammara Mushtaq, et al.
Antimicrobial Agents and Chemotherapy|September 2, 2015
Clinical and economic benefits of fidaxomicin compared to vancomycin for Clostridium difficile infectionJason C Gallagher, Joseph P Reilly, Bhagyashri Navalkele, et al.
Open Forum Infectious Diseases|May 29, 2020
Seizures in an Immunocompetent Adult From Treatment of Latent Tuberculosis Infection: Is Isoniazid to Blame?Bhagyashri Navalkele, Maria X Bueno Rios, John D Wofford, et al.
American Journal of Infection Control|March 12, 2018
Comparison of complications in midlines versus central venous catheters: Are midlines safer than central venous lines?Ammara Mushtaq, Bhagyashri Navalkele, Maninder Kaur, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2016
Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial StewardshipShigehiko Karino, Keith S Kaye, Bhagyashri Navalkele, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2016
Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin-Tazobactam Compared to Those on Vancomycin and CefepimeBhagyashri Navalkele, Jason M Pogue, Shigehiko Karino, et al.
Pageof 2